Skip to main content
. Author manuscript; available in PMC: 2021 Apr 9.
Published in final edited form as: Circ Cardiovasc Imaging. 2020 Apr 9;13(4):e009986. doi: 10.1161/CIRCIMAGING.119.009986

Table 4:

Associations between Inconclusive Test Results and Process of Care and Outcomes by Test Type

Frequency of Event (# Events/Sample Size) Unadjusted Adjusted*
Process of Care Conclusive Positive or Inconclusive Conclusive Negative Odds Ratio (95% CI) P-value Odds Ratio (95% CI) P-value
Overall Stress
Referral to second NIT within 90 days of first NIT
 Conclusive Positive vs. Conclusive Negative 145/564 (25.71%) 299/3531 (8.47%) 3.74 (2.99–4.68) <0.001 3.59 (2.85–4.53) <0.001
 Inconclusive vs. Conclusive Negative 64/438 (14.61%) 299/3531 (8.47%) 1.85 (1.38–2.47) <0.001 1.91 (1.42–2.56) <0.001
Referral to ICA within 90 days of Randomization
 Conclusive Positive vs. Conclusive Negative 263/564 (46.63%) 85/3531 (2.41%) 35.43 (27.00–46.47) <0.001 34.62 (26.08–45.98) <0.001
 Inconclusive vs. Conclusive Negative 24/438 (5.48%) 85/3531 (2.41%) 2.35 (1.48–3.74) <0.001 2.36 (1.47–3.78) <0.001
CTA
Referral to second NIT within 90 days of first NIT
 Conclusive Positive vs. Conclusive Negative 124/534 (23.22%) 324/3844 (8.43%) 3.29 (2.61–4.14) <0.001 2.97 (2.32–3.78) <0.001
 Inconclusive vs. Conclusive Negative 109/299 (36.45%) 324/3844 (8.43%) 6.23 (4.80–8.10) <0.001 5.95 (4.52–7.85) <0.001
Referral to ICA within 90 days of Randomization
 Conclusive Positive vs. Conclusive Negative 354/534 (66.29%) 159/3844 (4.14%) 45.57 (35.87–57.91) <0.001 42.81 (33.18–55.24) <0.001
 Inconclusive vs. Conclusive Negative 70/299 (23.41%) 159/3844 (4.14%) 7.08 (5.19–9.67) <0.001 6.49 (4.67–9.02) <0.001
Outcome Hazard Ratio (95% CI) P-value Hazard Ratio (95% CI) P-value
Overall Stress
All-cause death/MI/UAH
 Conclusive Positive vs. Conclusive Negative 47/564 (8.33%) 69/3531 (1.95%) 4.45 (3.07–6.45) <0.001 3.50 (2.38–5.15) <0.001
 Inconclusive vs. Conclusive Negative 16/438 (3.65%) 69/3531 (1.95%) 1.90 (1.10–3.28) 0.021 1.81 (1.05–3.13) 0.034
CV Death/MI
 Conclusive Positive vs. Conclusive Negative 19/564 (3.37%) 43/3531 (1.22%) 2.74 (1.60–4.71) <0.001 1.96 (1.11–3.46) 0.019
 Inconclusive vs. Conclusive Negative 11/438 (2.51%) 43/3531 (1.22%) 2.09 (1.08–4.06) 0.029 2.04 (1.05–3.97) 0.037
CTA
All-cause death/MI/UAH
 Conclusive Positive vs. Conclusive Negative 49/534 (9.18%) 83/3844 (2.16%) 4.48 (3.15–6.38) <0.001 3.66 (2.51–5.35) <0.001
 Inconclusive vs. Conclusive Negative 15/299 (5.02%) 83/3844 (2.16%) 2.43 (1.40–4.20) 0.002 1.85 (1.02–3.36) 0.044
CV Death/MI
 Conclusive Positive vs. Conclusive Negative 14/534 (2.62%) 45/3844 (1.17%) 2.26 (1.24–4.12) 0.008 1.66 (0.88–3.15) 0.120
 Inconclusive vs. Conclusive Negative 4/299 (1.34%) 45/3844 (1.17%) 1.18 (0.43–3.29) 0.746 0.74 (0.23–2.43) 0.623

ICA = invasive coronary angiography, MI = myocardial infarction, UAH = unstable angina hospitalization.

*

Adjusted model controls for NIT modality (stress test vs. CTA), age, sex, BMI, diabetes, smoker (ever), CAD equivalent, site characterization of chest pain, provider estimation of likelihood of obstructive epicardial disease (high or very high), hypertension, dyslipidemia, family history of premature CAD, participate in physical activity, Framingham Risk Score (2008), and Diamond-Forrester (2011).